Jeegar Pravinkumar Patel

Jeegar Pravinkumar Patel is a declared insider of Evommune, Inc., with filings sourced from SEC (Form 4). In total, 4 filings cover trades dated from 7 November 2025 to 22 June 2026.

The open-market record consists of 1 sale, with no purchase. The amount is not disclosed for 1 filing. Other entries cover 1 share grant and 1 option exercise. Since January 2026: no purchases and 1 sale on the market.

Most recently, on 24 June 2026, the filings show an option exercise in Evommune, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.